FDA Import Refusal SCS-1842138-1/11/1 — Merz Pharmaceuticals GmbH
The FDA refused shipment SCS-1842138-1/11/1 from Merz Pharmaceuticals GmbH (Germany) on Jun 24, 2022. The refused product falls under Drugs and Biologics — BOTOX. Cited charges: 118,472,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 24, 2022
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 65QCZ02 BOTOX
- Charges
- 118,472,75